Literature DB >> 18475378

Detection of human papillomavirus DNA by AffiProbe HPV-DNA test kit in cervical scrapes or biopsies-histopathologic correlates.

P Nieminen1, T Jalava, A Kallio, M Ranki, J Paavonen.   

Abstract

OBJECTIVE: The aim of this study was to evaluate and compare the efficacy of punch biopsies and cervical scrapes in the detection of human papillomavirus (HPV) DNA from the cervix and compare the results with the histopathologic diagnosis.
METHODS: The specimens were collected simultaneously, and HPV DNA was detected using a liquid hybridization test.
RESULTS: Biopsies and scrapes were equally efficient, but each detected only two-thirds of all HPV-DNA-positive patients. Thus, the positivity rate increased when both tests were used. Overall, 13% of patients with normal histopathology, 38% of patients with benign atypia, and 66% of patients with squamous intraepithelial lesions (SIL) were HPV-DNA positive. HPV-DNA 16 was found in 54% of HPV-DNA-positive patients with SIL, in 20% of HPV-DNA-positive patients with atypia, and in none of patients with normal histopathology.
CONCLUSIONS: The liquid hybridization test used in this study detects HPV DNA equally efficiently from both biopsies and scrapes. The test can be performed in 1 working day. However, the sensitivity of the test is low, and it only detects a limited number of HPV types.

Entities:  

Year:  1994        PMID: 18475378      PMCID: PMC2364372          DOI: 10.1155/S1064744994000517

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  14 in total

1.  Comparison of HPV detection in parallel biopsies and cervical scrapes by PCR.

Authors:  E Ask; A Jenkins; J Kaern; C Trope; B E Kristiansen
Journal:  APMIS       Date:  1992-08       Impact factor: 3.205

Review 2.  Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia.

Authors:  M H Schiffman
Journal:  J Natl Cancer Inst       Date:  1992-03-18       Impact factor: 13.506

3.  Cervical human papillomavirus deoxyribonucleic acid and cytologic evaluations in gynecologic outpatients.

Authors:  P Nieminen; V R Soares; M Aho; E Vesterinen; E Savia; A Vaheri; J Paavonen
Journal:  Am J Obstet Gynecol       Date:  1991-05       Impact factor: 8.661

4.  Diagnosis of cervical intraepithelial neoplasia and human papillomavirus infection: punch biopsy versus cervical smear.

Authors:  G Gitsch; A Reinthaller; G Tatra; G Breitenecker
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

5.  Use of AffiProbe HPV test kit for detection of human papillomavirus DNA in genital scrapes.

Authors:  M Ranki; A W Leinonen; T Jalava; P Nieminen; V R Soares; J Paavonen; A Kallio
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

6.  Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia [corrected].

Authors:  J Cuzick; G Terry; L Ho; T Hollingworth; M Anderson
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

7.  Human papillomavirus detection from the female genital tract: combined vs. separate scrape methods.

Authors:  J Mäenpää; P Arstila; M Ranki
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1992-05-13       Impact factor: 2.435

8.  Polymerase chain reaction and direct DNA tests in detection of human papillomavirus (HPV) DNA in cytologically normal and abnormal cervical smears. Scandinavian Multicenter Study Group.

Authors: 
Journal:  Acta Obstet Gynecol Scand       Date:  1992-02       Impact factor: 3.636

9.  Colposcopic diagnosis and treatment of cervical dysplasia at a single clinic visit. Experience of low-voltage diathermy loop in 1000 patients.

Authors:  M A Bigrigg; B W Codling; P Pearson; M D Read; G R Swingler
Journal:  Lancet       Date:  1990-07-28       Impact factor: 79.321

10.  Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types.

Authors:  A T Lorincz; R Reid; A B Jenson; M D Greenberg; W Lancaster; R J Kurman
Journal:  Obstet Gynecol       Date:  1992-03       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.